Aqr Capital Management LLC Exelixis, Inc. Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

A detailed history of Aqr Capital Management LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 3,156,148 shares of EXEL stock, worth $104 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

3,156,148

Previous 3,281,578 3.82%

Holding current value

$104 Million

Previous $73.7 Million 11.07%

% of portfolio

0.11%

Previous 0.11%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$21.96 - $27.6 $2.75 Million - $3.46 Million	-125,430 Reduced 3.82%	3,156,148 $81.9 Million
Q2 2024 Aug 14, 2024	BUY	$20.34 - $23.73 $7.53 Million - $8.78 Million	370,199 Added 12.72%	3,281,578 $73.7 Million
Q1 2024 May 15, 2024	BUY	$20.17 - $23.93 $14.8 Million - $17.5 Million	732,674 Added 33.63%	2,911,379 $69.1 Million
Q4 2023 Feb 14, 2024	BUY	$19.25 - $24.13 $3.14 Million - $3.93 Million	162,867 Added 8.08%	2,178,705 $52.3 Million
Q3 2023 Nov 14, 2023	BUY	$19.04 - $22.74 $2.18 Million - $2.6 Million	114,267 Added 6.01%	2,015,838 $44 Million
Q2 2023 Aug 14, 2023	SELL	$18.17 - $20.48 $7.92 Million - $8.93 Million	-435,829 Reduced 18.65%	1,901,571 $36.3 Million
Q1 2023 May 15, 2023	SELL	$16.3 - $19.41 $4.71 Million - $5.61 Million	-289,203 Reduced 11.01%	2,337,400 $45.4 Million
Q4 2022 Feb 14, 2023	BUY	$14.96 - $17.39 $13.8 Million - $16.1 Million	924,500 Added 54.32%	2,626,603 $42.1 Million
Q3 2022 Nov 14, 2022	SELL	$15.68 - $22.27 $4.12 Million - $5.85 Million	-262,616 Reduced 13.37%	1,702,103 $26.7 Million
Q2 2022 Aug 15, 2022	BUY	$17.44 - $23.16 $19 Million - $25.2 Million	1,089,169 Added 124.4%	1,964,719 $40.5 Million
Q1 2022 May 16, 2022	BUY	$17.03 - $22.67 $6.85 Million - $9.12 Million	402,127 Added 84.94%	875,550 $19.7 Million
Q4 2021 Feb 14, 2022	BUY	$15.84 - $21.88 $2.85 Million - $3.93 Million	179,734 Added 61.2%	473,423 $8.65 Million
Q3 2021 Nov 15, 2021	BUY	$16.3 - $21.14 $2.56 Million - $3.32 Million	156,822 Added 114.58%	293,689 $6.18 Million
Q2 2021 Aug 16, 2021	SELL	$17.95 - $25.56 $4.02 Million - $5.72 Million	-223,911 Reduced 62.06%	136,867 $2.46 Million
Q1 2021 May 17, 2021	SELL	$20.53 - $25.22 $18.5 Million - $22.7 Million	-899,201 Reduced 71.37%	360,778 $8.13 Million
Q4 2020 Feb 16, 2021	SELL	$18.39 - $24.8 $17.3 Million - $23.3 Million	-938,169 Reduced 42.68%	1,259,979 $24.9 Million
Q3 2020 Nov 16, 2020	SELL	$20.67 - $26.94 $28.6 Million - $37.3 Million	-1,384,151 Reduced 38.64%	2,198,148 $53.7 Million
Q2 2020 Aug 17, 2020	SELL	$16.46 - $27.42 $32.5 Million - $54.2 Million	-1,975,705 Reduced 35.55%	3,582,299 $82.7 Million
Q1 2020 May 15, 2020	SELL	$14.46 - $21.8 $29.6 Million - $44.6 Million	-2,047,034 Reduced 26.92%	5,558,004 $95.7 Million
Q4 2019 Feb 14, 2020	SELL	$15.15 - $18.89 $72.4 Million - $90.3 Million	-4,777,850 Reduced 38.58%	7,605,038 $134 Million
Q3 2019 Nov 14, 2019	SELL	$17.68 - $22.65 $23.2 Million - $29.7 Million	-1,310,066 Reduced 9.57%	12,382,888 $219 Million
Q2 2019 Aug 14, 2019	SELL	$18.93 - $24.75 $40.9 Million - $53.5 Million	-2,159,602 Reduced 13.62%	13,692,954 $293 Million
Q1 2019 May 14, 2019	BUY	$19.6 - $24.76 $98.4 Million - $124 Million	5,021,444 Added 46.36%	15,852,556 $377 Million
Q4 2018 Feb 14, 2019	BUY	$13.65 - $21.8 $107 Million - $172 Million	7,871,625 Added 265.98%	10,831,112 $213 Million
Q3 2018 Nov 15, 2018	SELL	$15.87 - $22.4 $22.9 Million - $32.3 Million	-1,442,420 Reduced 32.77%	2,959,487 $52.4 Million
Q2 2018 Aug 14, 2018	SELL	$18.56 - $22.45 $57 Million - $69 Million	-3,072,697 Reduced 41.11%	4,401,907 $94.7 Million
Q1 2018 May 15, 2018	BUY	$22.15 - $31.89 $3.29 Million - $4.74 Million	148,672 Added 2.03%	7,474,604 $166 Million
Q4 2017 Feb 14, 2018	BUY	$24.23 - $30.93 $31.7 Million - $40.5 Million	1,307,991 Added 21.73%	7,325,932 $223 Million
Q3 2017 Nov 14, 2017	BUY	$23.35 - $29.24 $141 Million - $176 Million	6,017,941	6,017,941 $146 Million

Others Institutions Holding EXEL

# of Institutions

508

Shares Held

243M

Call Options Held

2.54M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account

Aqr Capital Management LLC Exelixis, Inc. Transaction History